Albemarle Strategic Growth Presentation
Specialties Overview
Y/Y Q3 Performance Drivers
Net sales down -20% (price³ -13%, volume -7%); adjusted EBITDA down 65%
Decreased sales due to lower volumes and prices impacted by weaker demand,
particularly for consumer electronics
Adjusted EBITDA impacted by weakness in certain end-use markets including
consumer, industrial electronics, and elastomers
FY 2023 Outlook (as of Nov 1, 2023)
Specialties FY 2023 adj. EBITDA expected to be down 40-45% Y/Y, down from previous
outlook
Continued softness in consumer electronics and elastomers; stronger demand in other
Specialties end-markets, including oilfield services, agriculture, and pharmaceuticals
Operating normally at JBC (Jordan Bromine Company); monitoring potential impacts of
the current situation in the Middle East
Drivers/Sensitivities
GDP+ growth with diverse applications and end-markets in mobility, energy,
connectivity, and health
Supported by underlying trends in digitalization and electrification
Q3 2023 Performance
(in millions)
Net Sales
Q3 2023
Y/Y
$353
-20%
Net Sales ex FX1
$352
-20%
Adj. EBITDA4
$46
-65%
Adj. EBITDA ex FX1,4
$53
-60%
13%
-1730 bps
Adj. EBITDA Margin ex FX1,4
15%
-1530 bps
Adj. EBITDA Margin4
Historical Trend (TTM)
Adjusted EBITDA
Adjusted EBITDA Margin
$543M
$527M
$537M
$450M
$362M
32%
31%
30%
27%
23%
Note: Numbers may not reconcile due to rounding. 1 Net of FX impacts. 2 Sales based on historical average. 3 Includes FX impact.
4 See appendix for non-GAAP reconciliations.
3Q22
4Q22
1Q23
2Q23
3Q23
Albemarle 30View entire presentation